Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Tuesday’s Trading Day
54.20 -1.07 / -1.94%
As of Sep 01
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
55.00 +0.80 / +1.48%
Volume: 655.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line3.2B3.7B4.5B4.7B
Total Other Cash Flow254.3M-358.3M-291.1M808.8M
Funds From Operations3.9B3.8B4.7B6.0B
Funds From/For Other Operating Expenses-81.6M-47.5M47.3M380.7M
Net Cash Flow - Operating Activities4.0B3.9B4.6B5.6B
InvestingIncrease In Investments-37.0M-86.9M0.000.00
Decrease In Investments0.000.00149.8M401.8M
Capital Expenditures-577.5M-585.0M-577.5M-707.2M
Fixed Asset Disposal13.2M9.2M5.5M709.0K
Other Investing - Uses0.000.000.00-61.2M
Net Cash Flow Investing-650.1M-706.1M-494.6M-365.8M
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings0.
Long Term Debt Reduction-95.3M-87.1M0.000.00
Net Proceeds Stock Sale0.
Common Preferred Redeemed-2.0B-2.1B-2.5B-2.6B
Common Dividends-1.1B-1.3B-1.7B-2.1B
Cash Dividends Paid - Total-1.1B-1.3B-1.7B-2.1B
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing-3.2B-3.5B-4.2B-4.7B
Exchange RateEffect of Exchange Rate on Cash-3.0M-1.4M-12.5M12.1M
Net Change In Cash209.2M-346.3M-83.8M548.6M